{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-011613","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2026-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.656297+00:00","generated_at":"2026-05-15T09:37:49.894015+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Evofem and Windtree mutually terminate PHEXXI supply agreement, no fees","bullets":["License and Supply Agreement for PHEXXI manufacturing terminated March 13, 2026, by mutual consent.","Windtree had not established required manufacturing capabilities; no termination fees payable.","Windtree must return all Evofem confidential information and property; survival provisions remain.","Agreement originally entered March 20, 2025, and amended March 28, 2025, now terminated."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-011613","json":"https://secwatch.observer/filing/0001493152-26-011613.json","markdown":"https://secwatch.observer/filing/0001493152-26-011613.md","text":"https://secwatch.observer/filing/0001493152-26-011613.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226011613/0001493152-26-011613-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226011613/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:37:49.894015+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6f76ddc7440e5bb8fb5fc9fac78f54c7fbb7870c","claim":"Evofem Biosciences, Inc. terminated Termination Agreement with Windtree Therapeutics, Inc. (effective 2026-03-13).","evidence_excerpt":"the Company and Windtree entered into a Termination Agreement (the “Termination Agreement”) pursuant to which the parties mutually consented to the termination of the Agreement, effective as of such date.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226011613/0001493152-26-011613-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"supply"},{"label":"Counterparty","value":"Windtree Therapeutics, Inc."},{"label":"Effective","value":"2026-03-13"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}